DE69813549D1 - Verwendung von dextran und weiteren nicht-sulfatierten polysacchariden zur förderung der mukusklärung - Google Patents

Verwendung von dextran und weiteren nicht-sulfatierten polysacchariden zur förderung der mukusklärung

Info

Publication number
DE69813549D1
DE69813549D1 DE69813549T DE69813549T DE69813549D1 DE 69813549 D1 DE69813549 D1 DE 69813549D1 DE 69813549 T DE69813549 T DE 69813549T DE 69813549 T DE69813549 T DE 69813549T DE 69813549 D1 DE69813549 D1 DE 69813549D1
Authority
DE
Germany
Prior art keywords
dextran
mucus
clarification
sulfated polysaccharides
cystic fibrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69813549T
Other languages
English (en)
Other versions
DE69813549T2 (de
Inventor
Malcolm King
P Speert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alberta
University of British Columbia
Original Assignee
University of Alberta
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Alberta, University of British Columbia filed Critical University of Alberta
Publication of DE69813549D1 publication Critical patent/DE69813549D1/de
Application granted granted Critical
Publication of DE69813549T2 publication Critical patent/DE69813549T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69813549T 1997-06-30 1998-06-30 Verwendung von dextran und weiteren nicht-sulfatierten polysacchariden zur förderung der mukusklärung Expired - Fee Related DE69813549T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CA002209342A CA2209342A1 (en) 1997-06-30 1997-06-30 Use of dextran and other oligomeric saccharides to improve airway clearance
CA2209342 1997-06-30
CA002233805A CA2233805A1 (en) 1997-06-30 1998-03-31 Use of dextran and other polysaccharides to improve mucus clearance
CA2233805 1998-03-31
PCT/CA1998/000628 WO1999001141A1 (en) 1997-06-30 1998-06-30 Use of dextran and other polysaccharides to improve mucus clearance

Publications (2)

Publication Number Publication Date
DE69813549D1 true DE69813549D1 (de) 2003-05-22
DE69813549T2 DE69813549T2 (de) 2004-02-26

Family

ID=25679458

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69813549T Expired - Fee Related DE69813549T2 (de) 1997-06-30 1998-06-30 Verwendung von dextran und weiteren nicht-sulfatierten polysacchariden zur förderung der mukusklärung

Country Status (9)

Country Link
EP (1) EP0988041B1 (de)
AT (1) ATE237335T1 (de)
AU (1) AU741849B2 (de)
CA (2) CA2209342A1 (de)
DE (1) DE69813549T2 (de)
ES (1) ES2196571T3 (de)
HK (1) HK1026854A1 (de)
NZ (1) NZ501802A (de)
WO (1) WO1999001141A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001269263A1 (en) * 2000-07-01 2002-01-14 Innovata Biomed Limited Medicaments containing dextrin for treating respiratory disorders such as cysticfibrosis
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
WO2008003682A1 (en) * 2006-07-06 2008-01-10 Novartis Ag Non invasive method for assessing mucus clearance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015216A1 (en) * 1990-04-05 1991-10-17 Kennedy Thomas P Method and medicament for prevention or medication of human leucocyte elastase-mediated pulmonary diseases
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans

Also Published As

Publication number Publication date
ATE237335T1 (de) 2003-05-15
AU741849B2 (en) 2001-12-13
ES2196571T3 (es) 2003-12-16
NZ501802A (en) 2002-03-28
CA2209342A1 (en) 1998-12-30
AU8098098A (en) 1999-01-25
CA2233805A1 (en) 1998-12-30
EP0988041A1 (de) 2000-03-29
EP0988041B1 (de) 2003-04-16
HK1026854A1 (en) 2000-12-29
DE69813549T2 (de) 2004-02-26
WO1999001141A1 (en) 1999-01-14

Similar Documents

Publication Publication Date Title
WO1999014346A3 (en) SENSE mRNA THERAPY
BR9508322A (pt) Uso de quitosan e de um polissacarídeo imobilizado no mesmo processo para estimular e/ou acelerar regeneração de tecido rígido e implante destinado para integração em tecido rígido
EP1381631A4 (de) Menschliche timp-1-antikörper
HK1097841A1 (en) Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes
BRPI0015533B8 (pt) enzima alfa-l-iduronidase humana recombinante, composição farmacêutica compreendendo a mesma e método para sua purificação
NO20000752D0 (no) Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser
BR9712731A (pt) Fitase a partir de feijões de soja germinados
BR9913152A (pt) Terapias para tratamento de doenças pulmonares
BR0007787A (pt) Composição de amido, uso de uma composição de amido processo para preparar um alimento espesso, alimento, e, confeito
BR9801736A (pt) Processo de produção de dextrano.
PT1537274E (pt) Tratamento enzimatico de feltros de prensa
BRPI0406477A (pt) Composição, agente de tratamento de óleo, e, métodos de produção de uma composição e de tratamento de óleo
WO1999058691A3 (en) Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
DE69813549D1 (de) Verwendung von dextran und weiteren nicht-sulfatierten polysacchariden zur förderung der mukusklärung
Dumas et al. Collagenase in mineralized tissues of human teeth
DK0921806T3 (da) Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser
AR042019A1 (es) N-acetilgalactosamina-4-sulfatasa precursora, composiciones farmaceuticas que la contienen , metodos de tratamiento que la utilizan y metodos para producirla y purificarla
ATE404208T1 (de) Uridin-therapie für patienten mit erhöhten purin- werten
Vieira et al. Extensive heterogeneity of proteoglycans bearing fucose-branched chondroitin sulfate extracted from the connective tissue of sea cucumber
EA200200518A1 (ru) Способ и композиция для лечения заболеваний легких
SE9900834D0 (sv) Novel combination
DK1037642T3 (da) Modificerede polysaccharider med ændret biologisk genkendelse
WO1999058098A3 (en) HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO
WO1994029452A3 (en) Enzymatic rna molecules and their application in the treatment of fibrosis and fibrous tissue disease
BRPI0411353A (pt) moléculas de corina modificadas tendo seqüências de ativação substitutas e aplicações das mesmas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOETERS & LIECK, 81541 MUENCHEN

8339 Ceased/non-payment of the annual fee